Vedroprevir (GS-9451) is an inhibitor for HCV NS3/4A protease with an IC 50 of 3.2 nM. Vedroprevir is also an inhibitor for breast cancer resistant protein ( BCRP ) with an IC 50 of 1.4 μM. Vedroprevir inhibits P-gp , MRP1 and MRP2 with IC 50 of 34, 14.9 and 12 μM, respectively. Vedroprevir exhibits good pharmacokinetic characteristics in rats and dogs.
Products | Products > Disease Areas > Infection | Products > Signaling Pathways > Anti-infection | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Research Areas > Infection | Products > Signaling Pathways > HCV Protease | Products > Signaling Pathways > BCRP | Products > Signaling Pathways > P-glycoprotein
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.